Immunotherapeutic Agents. A NIR-light-activated and lysosomal-targeted PtII metallacycle for evoking of immunogenic cell death that potentiates cancer immunotherapy of deep-seated tumors is reported by Peter J. Stang, Yan Sun, Yao Sun et al. in their Research Article (e202406392).
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: